Delhi: AIIMS to start screening children for Covaxin trials from today

The All India Institute of Medical Sciences (AIIMS) in Delhi will begin screening of children aged 2 to 18 years for Covaxin clinical trials from today. Covaxin is ndigenously developed anti-Covid vaccine. It is developed by Hyderabad-based biotechnology company Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

from IndiaTV India: Google News Feed

Get Breaking news, Live news, and latest news from India and around the world on, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News